我的購物車 (0)
我的帳號資料
我的訂單紀錄
我的學校教授
我的學校課程

[ Tips ] 一分鐘使用導覽
搜尋 
請輸入欲查詢之關鍵字
 
　 進階搜尋
依主題瀏覽 
依商品類型瀏覽 
依出版日期瀏覽 
依作者瀏覽(姓) 
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
V
W
Y
Z
銷售排行榜 
 您所選取的商品項目

> Endo Pharmaceuticals (A): From LBO to ...?

商品編號： 9-806-064
出版日期： 2006/01/30
作者姓名：
Hamermesh, Richard G.;Delacey, Brian J.
商品類別： Entrepreneurship
商品規格： 21p

再版日期： 2007/05/21
地域： United States
產業： Health care services;Pharmaceuticals
個案年度： 1999 -  1999

 


商品敘述：

Endo Pharmaceuticals was formed in 1997 as a leveraged buyout spin-off from DuPont Merck. In 1999, it must decide whether to do an IPO or merge with a smaller company.


涵蓋領域：

Leveraged buyouts;Mergers;Entrepreneurship;IPO;Entrepreneurial management;Spin-offs;Private equity;Growth strategy


相關資料：

Supplement, (9-806-065), 1p, by Richard G. Hamermesh, Brian J. Delacey;
Supplement, (9-806-066), 13p, by Richard G. Hamermesh, Brian J. Delacey;
Supplement, (9-806-067), 1p, by Richard G. Hamermesh, Brian J. Delacey;
Supplement, (9-806-081), 1p, by Richard G. Hamermesh, Brian J. Delacey;
Supplement, (9-806-082), 3p, by Richard G. Hamermesh, Brian J. Delacey;
Case Teaching Note, (5-807-065), 9p, by Richard G. Hamermesh, Brian J. Delacey, Erin Seefeld;
Case Teaching Note, (9-807-166), 16p, by Richard G. Hamermesh, Brian J. Delacey, Erin Seefeld

哪些人也有訂購？